Benzinga | Jan 29, 2021 06:09AM EST

Piper Sandler Downgrades Glaukos to Neutral, Raises Price Target to $80

Piper Sandler analyst Matt O'Brien downgrades Glaukos (NYSE:GKOS) from Overweight to Neutral and raises the price target from $70 to $80.